Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?

<p>Abstract</p> <p>Background</p> <p>Chronic renal disease is a serious complication of long-term intravenous drug use (IVDU). Recent reports have postulated a changing pattern of underlying nephropathy over the last decades.</p> <p>Methods</p> <p&g...

Full description

Bibliographic Details
Main Authors: Jung Oliver, Haack Hans, Buettner Maike, Betz Christoph, Stephan Christoph, Gruetzmacher Peter, Amann Kerstin, Bickel Markus
Format: Article
Language:English
Published: BMC 2012-11-01
Series:BMC Nephrology
Subjects:
Online Access:http://www.biomedcentral.com/1471-2369/13/151
_version_ 1818758791656636416
author Jung Oliver
Haack Hans
Buettner Maike
Betz Christoph
Stephan Christoph
Gruetzmacher Peter
Amann Kerstin
Bickel Markus
author_facet Jung Oliver
Haack Hans
Buettner Maike
Betz Christoph
Stephan Christoph
Gruetzmacher Peter
Amann Kerstin
Bickel Markus
author_sort Jung Oliver
collection DOAJ
description <p>Abstract</p> <p>Background</p> <p>Chronic renal disease is a serious complication of long-term intravenous drug use (IVDU). Recent reports have postulated a changing pattern of underlying nephropathy over the last decades.</p> <p>Methods</p> <p>Retrospective investigation including all patients with prior or present IVDU that underwent renal biopsy because of chronic kidney disease between 01.04.2002 and 31.03.2012 in the city of Frankfurt/Main, Germany.</p> <p>Results</p> <p>Twenty four patients with IVDU underwent renal biopsy because of progressive chronic kidney disease or proteinuria. Renal AA-amyloidosis was the predominant cause of renal failure in 50% of patients. Membranoproliferative glomerulonephritis (GN) was the second most common cause found in 21%. Patients with AA-amyloidosis were more likely to be HIV infected (67 vs.17%; p=0.036) and tended to have a higher rate of repeated systemic infections (92 vs. 50%; p=0.069). Patients with AA-amyloidosis presented with progressive renal disease and nephrotic-range proteinuria but most patients had no peripheral edema or systemic hypertension. Development of proteinuria preceded the decline of GFR for approximately 1–2 years.</p> <p>Conclusions</p> <p>AA-amyloidosis was the predominant cause of progressive renal disease in the last 10 years in patients with IVDU. The highest rate of AA-amyloidosis observed was seen in HIV infected patients with IVDU. We speculate that chronic HIV-infection as well as the associated immunosuppression might promote development of AA-amyloidosis by increasing frequency and duration of infections acquired by IVDU.</p>
first_indexed 2024-12-18T06:32:27Z
format Article
id doaj.art-dec06fb75e124229866836e1ac42bef2
institution Directory Open Access Journal
issn 1471-2369
language English
last_indexed 2024-12-18T06:32:27Z
publishDate 2012-11-01
publisher BMC
record_format Article
series BMC Nephrology
spelling doaj.art-dec06fb75e124229866836e1ac42bef22022-12-21T21:17:53ZengBMCBMC Nephrology1471-23692012-11-0113115110.1186/1471-2369-13-151Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?Jung OliverHaack HansBuettner MaikeBetz ChristophStephan ChristophGruetzmacher PeterAmann KerstinBickel Markus<p>Abstract</p> <p>Background</p> <p>Chronic renal disease is a serious complication of long-term intravenous drug use (IVDU). Recent reports have postulated a changing pattern of underlying nephropathy over the last decades.</p> <p>Methods</p> <p>Retrospective investigation including all patients with prior or present IVDU that underwent renal biopsy because of chronic kidney disease between 01.04.2002 and 31.03.2012 in the city of Frankfurt/Main, Germany.</p> <p>Results</p> <p>Twenty four patients with IVDU underwent renal biopsy because of progressive chronic kidney disease or proteinuria. Renal AA-amyloidosis was the predominant cause of renal failure in 50% of patients. Membranoproliferative glomerulonephritis (GN) was the second most common cause found in 21%. Patients with AA-amyloidosis were more likely to be HIV infected (67 vs.17%; p=0.036) and tended to have a higher rate of repeated systemic infections (92 vs. 50%; p=0.069). Patients with AA-amyloidosis presented with progressive renal disease and nephrotic-range proteinuria but most patients had no peripheral edema or systemic hypertension. Development of proteinuria preceded the decline of GFR for approximately 1–2 years.</p> <p>Conclusions</p> <p>AA-amyloidosis was the predominant cause of progressive renal disease in the last 10 years in patients with IVDU. The highest rate of AA-amyloidosis observed was seen in HIV infected patients with IVDU. We speculate that chronic HIV-infection as well as the associated immunosuppression might promote development of AA-amyloidosis by increasing frequency and duration of infections acquired by IVDU.</p>http://www.biomedcentral.com/1471-2369/13/151AA-amylodosisIVDUChronic kidney diseaseHIV
spellingShingle Jung Oliver
Haack Hans
Buettner Maike
Betz Christoph
Stephan Christoph
Gruetzmacher Peter
Amann Kerstin
Bickel Markus
Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
BMC Nephrology
AA-amylodosis
IVDU
Chronic kidney disease
HIV
title Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
title_full Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
title_fullStr Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
title_full_unstemmed Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
title_short Renal AA-amyloidosis in intravenous drug users – a role for HIV-infection?
title_sort renal aa amyloidosis in intravenous drug users a role for hiv infection
topic AA-amylodosis
IVDU
Chronic kidney disease
HIV
url http://www.biomedcentral.com/1471-2369/13/151
work_keys_str_mv AT jungoliver renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT haackhans renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT buettnermaike renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT betzchristoph renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT stephanchristoph renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT gruetzmacherpeter renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT amannkerstin renalaaamyloidosisinintravenousdrugusersaroleforhivinfection
AT bickelmarkus renalaaamyloidosisinintravenousdrugusersaroleforhivinfection